Odyssey HealthODYY -3.33% EV-to-FCF is -3.29 as of Jun. 28, 2026. The stock has 4 warning signs investors should review. Among 419 Medical Devices & Instruments companies, Odyssey Health ranks worse than 238663.25% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Odyssey Health's Enterprise Value is $3.08 Mil.
Odyssey Health's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.94 Mil. Therefore, Odyssey Health's EV-to-FCF for today is -3.29.
The historical rank and industry rank for Odyssey Health's EV-to-FCF or its related term are showing as below:
ODYY'
s EV-to-FCF Range Over the Past 10 Years
Min: -3.29 Med: 0 Max: 0
Current: -3.29
ODYY's EV-to-FCF is ranked worse than 100% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.67
vs ODYY: -3.29
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Odyssey Health's PE Ratio (TTM) for today is calculated as:
Odyssey Health's share price for today is $0.00725.
Odyssey Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Odyssey Health EV-to-FCF Related Terms
Odyssey Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Odyssey Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Odyssey Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Odyssey Health EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Odyssey Health's EV-to-FCF falls into.
Odyssey Health's current Enterprise Value is $3.08 Mil.
Odyssey Health's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Odyssey Health (ODYY) has a EV-to-FCF of -3.29 as of Jun. 28, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Odyssey Health and its competitors. According to the industry distribution chart, Odyssey Health ranks #999999 out of 419 companies in the Medical Devices & Instruments industry.
Is Odyssey Health's EV-to-FCF too high?
Odyssey Health's current EV-to-FCF is -3.29. Based on the distribution chart, Odyssey Health ranks #999999 out of 419 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Odyssey Health's EV-to-FCF compare to PFSA and ESMC?
According to the Medical Devices & Instruments industry distribution chart, Odyssey Health ranks #999999 out of 419 companies for EV-to-FCF. This places Odyssey Health in the lower half of its industry. The industry median EV-to-FCF is 22.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.67, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Odyssey Health and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Odyssey Health's current EV-to-FCF is -3.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current EV-to-FCF of -3.29. The current EV-to-FCF is -3.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Odyssey Health (ODYY), the current EV-to-FCF is -3.29 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ODYY has been successfully added to your 